Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Former “String Of Pearls” Strategist Tabbed To Lead Teva’s Continuing Diversification

Jan 03 2012

Related Content

Despite Short-Term Glitches, Teva Maintains It Is On Track To Double Revenues By 2015

Feb 08 2011

In Cephalon, Teva Will Get An Expanded Innovative R&D And Branded Portfolio

May 03 2011

With Cephalon Deal, Teva Sees Opportunities For Niche Branded Drugs and Drug/Device Combinations

May 05 2011

Teva Buys Majority Stake In Japanese Generics Company For $460 Mil.

May 16 2011

Teva Stakes OTC Claim With P&G Joint Venture

Mar 24 2011

<i>Copaxone</i> Patent Suit: Is Teva Really Sure It Wants To Win The Case?

Sep 26 2011

Related Companies

Teva Pharmaceutical Industries Ltd.

Bristol Myers Squibb Company

Lonza Group AG

Procter & Gamble

Cephalon, Inc.

Teva Pharmaceutical Industries Ltd.

Novartis AG

OSI Systems, Inc.

ratiopharm

Forest Laboratories, Inc.

Additional Topics

Europe Israel Middle East and Africa Strategy Leadership BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window